Navigation Links
Synthetic biology key in the 21st century
Date:12/18/2008

Washington, DC Among the 75 people Esquire magazine recently chose as the most influential in the 21st century are three researchers in an emerging discipline that combines science and engineering in order to design and build novel biological functions and systems otherwise known as synthetic biology.

The promise of this burgeoning scientific field lies in the potential to apply engineering principles to the fundamental components of biology. This includes the design and construction of new biological parts, devices, and systems (e.g., tumor-seeking microbes for cancer treatment), as well as the re-design of existing, natural biological systems for useful purposes (e.g., plants making energy).

"Humans have been altering the genetic code of plants and animals for millennia, by selectively breeding individuals with desirable features. But more recent advances have enabled scientists to make new sequences of DNA from scratch. By combining these advances with the principles of modern engineering, scientists can now use computers and laboratory chemicals to design organisms that do new things -- like produce biofuels or excrete the precursors of medical drugs," says David Rejeski, the director of the Project.

But just how much about this field is covered in the media? And while these scientists featured in Esquire Drew Endy, Jay Keasling and Craig Venter may hold the keys to improved medial treatments and cleaner fuels, are there adequate controls and security measures to limit potential risks? The development of www.synbioproject.org marks an effort to answer those questions.

To provide a snapshot of the work to come, the Synthetic Biology Project announces the release of the landmark paper Trends in American and European Press Coverage of Synthetic Biology, which examines coverage of the field in recent years, as well as a quiz that tests your knowledge of synthetic biology.


'/>"/>

Contact: Colin Finan
colin.finan@wilsoncenter.org
202-691-4321
Project on Emerging Nanotechnologies
Source:Eurekalert

Page: 1

Related biology news :

1. Synthetic biology: Is ethics a showstopper?
2. Synthetic virus supports a bat origin for SARS
3. UNC scientists teach enzyme to make synthetic heparin in more varieties
4. Biosynthetics production with detours
5. Synthetic Biology: Coming Up Fast!
6. Caltech engineers build firast-ever multi-input plug-and-play synthetic RNA device
7. New synthetic form of protein holds promise to stop cancer spread
8. Synthetic moleculues could add spice to fight against cancer
9. Synthetic molecules emulate enzyme behavior for the first time
10. Synthetic cocoa chemical slows growth of tumors in human cell lines
11. Synthetic Biology: funders move to address social and ethical challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:6/1/2016)... 2016 Favorable Government Initiatives Coupled ... Criminal Identification to Boost Global Biometrics System Market Through ... Research report, " Global Biometrics Market By Type, ... Opportunities, 2011 - 2021", the global biometrics market is ... account of growing security concerns across various end use ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC ... today announced the opening of an IoT Center of ... strengthen and expand the development of embedded iris biometric ... unprecedented level of convenience and security with unmatched biometric ... one,s identity aside from DNA. EyeLock,s platform uses video ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the ... major shareholders, Clean Technology Fund I, LP and Clean ... based venture capital funds which together hold approximately ... fully diluted, as converted basis), that they have entered ... equity holdings in Biorem to TUS Holdings Co. Ltd. ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
Breaking Biology Technology: